WE ARE COMMITED

WE ARE COMMITTED TO ADVANCING THE GLOBAL HIV RESPONSE

If we want to end the epidemic, we need to commit to a few things first; ensuring equitable access to medicines for all people living with HIV, challenge health inequities across the globe, and continue to fight HIV related stigma.

HIV is not a solved problem and we won't stop until it is. That's a promise.

IMPROVING ACCESS TO OUR MEDICINES

SUPPORTING HEALTH EQUITY, EVERYWHERE

FIGHTING HIV STIGMA, ALWAYS.

COMMITMENT TO TESTING

WHAT WILL IT TAKE TO END HIV? IT TAKES A VILLAGE

Read more stories from ViiV here

In this article by Professor José Gatell, he shares his insights on what multidrug-resistance HIV is and his insights on how to manage such a complex condition.

In this article, Mercy Shibemba shares her hopes and aspirations for the future. She reflects on how living with HIV shaped her childhood and how her concept of healthy living may shift as she
gets older.

To lift the substantial burdens of daily treatment and social stigma associated with HIV. A cure is essential towards accomplishing our goal of ending the HIV epidemic. With this goal in mind, we are in pursuit of a cure for HIV.

NP-GBL-HVX-COCO-240022 July 2024

Reporting of side effects

If you get any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the GSK Reporting Tool link https://gsk.public.reportum.com/. By reporting side effects, you can help provide more information on the safety of this medicine.

If you are from outside the UK, you can report adverse events to GSK/ ViiV by selecting your region and market, here.